<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: This prospective clinical study examined the association between subclasses of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) and pulmonary manifestations in <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The cohort involved 329 patients: 214 patients with primary APS (PAPS) and 115 patients with secondary APS (SAPS) </plain></SENT>
<SENT sid="2" pm="."><plain>aPL analysis included detection of serum anticardiolipin antibodies [aCL (IgG/IgM)], β₂ <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I [β₂GPI (IgG/IgM)], and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: In SAPS, high aCL IgG levels (&gt; 100 PLU/mL) were more common in major pulmonary <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> (p = 0.006) and medium aCL IgG levels (41-99 PLU/mL) in adult <z:hpo ids='HP_0002098'>respiratory distress</z:hpo> syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ARDS</z:e>; p = 0.047) and fibrosing <z:mp ids='MP_0010922'>alveolitis</z:mp> (p = 0.002) </plain></SENT>
<SENT sid="4" pm="."><plain>aCL IgG antibodies were more common in SAPS (p = 0.037) </plain></SENT>
<SENT sid="5" pm="."><plain>In PAPS, fibrosing <z:mp ids='MP_0010922'>alveolitis</z:mp> was more common in patients with medium β₂GPI IgM levels (p = 0.0001) </plain></SENT>
<SENT sid="6" pm="."><plain>LA correlated with <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> (p = 0.03) and microthrombosis (p = 0.03) in SAPS, and with pulmonary microthrombosis (p = 0.03) in PAPS </plain></SENT>
<SENT sid="7" pm="."><plain>Males were more likely to develop secondary <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> when diagnosed with PAPS (p = 0.019) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Certain classes of aPL are associated with distinct pulmonary manifestation, indicating their predictive role and importance in diagnosis and treatment of APS </plain></SENT>
</text></document>